BIOGY Projected Dividend Yield
ADR/BioGaia AB (Sweden) ( OTCBB : BIOGY )BioGaia AB develops, markets and sells probiotic products. The products are primarily based on various strains of the lactic acid bacterium Lactobacillus reuteri in combination with packaging solutions to develop probiotic products with a long shelf life. Co.'s products include: ProTectis, which is used for the indication of digestive health, children and adults, and for prevention and treatment of colic, regurgitation, constipation, diarrhea; ProDentis, which is used for the indication of adults oral health, periodontal disease and gingivitis; and Gastrus, which is used for the indication of adults digestive health, and side effects from treatment of Helicobacter pylori infection. 19 YEAR PERFORMANCE RESULTS |
BIOGY Dividend History Detail BIOGY Dividend News BIOGY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2023 |
N/A |
May 08, 2023 |
May 09, 2023 |
May 30, 2023 |
0.2800 |
2023 Total: |
0.2800 |
||||
2022 |
N/A |
May 09, 2022 |
May 10, 2022 |
May 31, 2022 |
0.2950 |
2022 Total: |
0.2950 |
||||
2021 |
N/A |
May 07, 2021 |
May 10, 2021 |
Jun 01, 2021 |
0.0815 |
2021 Total: |
0.0815 |
||||
2020 |
N/A |
May 08, 2020 |
May 11, 2020 |
May 29, 2020 |
0.0762 |
2020 Total: |
0.0762 |